Luigi Cerbone

7PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Chemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 19, 2024
Nivolumab in pretreated pleural mesothelioma: Results from an observational real-world study of patients treated within the AIFA 5% Fund.

Luigi Cerbone, Sara Delfanti, Stefania Crivellari

|Mar 02, 2023
Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer.

Yoann Pradat, Julien Viot, Andrey A Yurchenko

|Jan 04, 2023
Unprecedented long-term survival in a patient with malignant pleural mesothelioma treated with subsequent systemic chemo- and immunotherapeutic regimens.

Luigi Cerbone, Sara Delfanti, Antonina M De Angelis

|Jan 04, 2023
Combined response of advanced cutaneous squamous cell carcinoma and renal cell carcinoma to immunotherapy: a case report.

Veronica Murianni, Luigi Cerbone, Pasquale Rescigno

|Nov 08, 2021
Durable response after immunotherapy discontinuation for delayed and severe immune-related adverse events: a case report.

Guido Pesola, Veronica Murianni, Sara Elena Rebuzzi

|Feb 08, 2021
The Effect of Concomitant Proton Pump Inhibitor and Cabozantinib on the Outcomes of Patients with Metastatic Renal Cell Carcinoma.

Elie Rassy, Luigi Cerbone, Edouard Auclin

Pageof 2

Frequent Collaborators

3 joint publications

Sara Elena Rebuzzi

2 joint publications

Sebastiano Buti

2 joint publications

Guido Pesola

2 joint publications

Veronica Murianni